Stability determination of solid lipid nanoparticles (SLN™) in aqueous dispersion after addition of electrolyte

被引:72
|
作者
Freitas, C [1 ]
Müller, RH [1 ]
机构
[1] Free Univ Berlin, Dept Pharmaceut Biopharmaceut & Biotechnol, D-12169 Berlin, Germany
关键词
solid lipid nanoparticles; stability; electrolytes; zeta potential; gelation; lipid modification;
D O I
10.1080/026520499289310
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The contribution of mono-, di- and trivalent ions to the destabilization of solid lipid nanoparticle (SLN(TM)) dispersions was investigated, i.e. particle growth and subsequent formation of semi-solid gels. Sodium, calcium and aluminium chloride were added in varying concentrations to a Compritol formulation which had proved to be highly sensitive towards destabilizing effects. Dispersions containing up to 10(-3) m sodium chloride remained stable for 14 days. The same concentrations of calcium or aluminium induced slight and rapid particle growth, respectively. Generally, a pronounced destabilizing effect was observed with increasing electrolyte concentration and increasing valence. Higher concentrations of electrolyte (10(-2), 10(-1) m) induced gelation of the systems. The extent of solidification was highly dependent on the crystallinity of the lipid phase. The recrystalization indices of the gels were distinctly higher compared to the liquid systems. Additionally, unstable modifications, being present in liquid dispersions, were transformed into stable ones with increasing solidification. The mechanisms of the destabilizing effect of the electrolytes are reduced electrostatic repulsion and transformation of the lipid Compritol to the beta' modification promoting gel formation.
引用
收藏
页码:59 / 71
页数:13
相关论文
共 50 条
  • [1] Chemical stability of the lipid matrices of solid lipid nanoparticles (SLN)-development of an analytical method and determination of long-term stability
    Radomska, A
    Dobrucki, R
    Müller, RH
    [J]. PHARMAZIE, 1999, 54 (12): : 903 - 909
  • [2] Incorporation of cyclosporin A in solid lipid nanoparticles (SLN)
    Ugazio, E
    Cavalli, R
    Gasco, MR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (02) : 341 - 344
  • [3] Cosmetic applications for solid lipid nanoparticles (SLN)
    Wissing, SA
    Müller, RH
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) : 65 - 68
  • [4] Encapsulation of retinoids in solid lipid nanoparticles (SLN®)
    Jenning, V
    Gohla, SH
    [J]. JOURNAL OF MICROENCAPSULATION, 2001, 18 (02) : 149 - 158
  • [5] Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase
    Freitas, C
    Müller, RH
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) : 125 - 132
  • [6] Investigations on the occlusive properties of solid lipid nanoparticles (SLN)
    Wissing, SA
    Lippacher, A
    Müller, RH
    [J]. JOURNAL OF COSMETIC SCIENCE, 2001, 52 (05): : 313 - 324
  • [7] Effect of Surfactant on Characteristics of Solid Lipid Nanoparticles (SLN)
    Kullavadee, Karn-orachai
    Uracha, Ruktanonchai
    Smith, Siwaporn Meejoo
    [J]. NANOMATERIALS: SYNTHESIS AND CHARACTERIZATION, 2012, 364 : 313 - +
  • [8] Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis
    Musielak, Ewelina
    Feliczak-Guzik, Agnieszka
    Nowak, Izabela
    [J]. MOLECULES, 2022, 27 (07):
  • [9] Solid lipid nanoparticles (SLN) for intravenous drug delivery
    Muller, RH
    zurMuhlen, A
    Freitas, C
    Mehnert, W
    [J]. 23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 184 - 185
  • [10] Comparison of wax and glyceride solid lipid nanoparticles (SLN®)
    Jenning, V
    Gohla, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) : 219 - 222